Skip to main content

Table 2 Serum folate level (median (25th–75th) and DNA methylation status (n (%)) in the three groups

From: Moderately high folate level may offset the effects of aberrant DNA methylation of P16 and P53 genes in esophageal squamous cell carcinoma and precancerous lesions

Variables

Control (n = 200)

EPL (n = 200)

ESCC (n = 200)

p value

Serum folate (μg/L)

29.14 (24.43–36.24)

25.72 (21.29–29.47)a

24.79 (20.73–29.85)a

< 0.001*

No. of p16 methylation

70 (35.0%)

92 (46.0%)b

126 (63.0%)b

< 0.05†

No. of p53 methylation

74 (36.5%)

84 (42.0%)

113 (56.5%)b

< 0.05†

  1. *p value of Kruskal-Wallis test
  2. †p value of Chi-square (χ2) test
  3. aCompared with control group, p < 0.05 (Mann-Whitney U test)
  4. bCompared with control group, p < 0.05 (Chi-square (χ2) test)